Free Market Health Drug List
Customize your policy alerts
Sign up for all Highmark Blueshield Neny policy alerts
Know when Highmark Blueshield Neny releases new policies or updates existing guidance.
Monitor payer policy activity
A consolidated list of drugs included in the Free Market Health program, separated by medical-benefit (HCPCS/J-codes and others) and pharmacy-benefit entries; affects providers, pharmacies, and members covered by Highmark Blueshield Neny enrolled in the Free Market Health program.
No material clinical or coverage changes in this revision.
Coverage — List-only Indications
List-only coverage indication
This part of the document provides an enumerated list of drugs included in the Free Market Health program; no utilization management criteria (e.g., prior authorization, step therapy) or exclusions are specified within these chunks.
List-only entries
This section is a roster of pharmacy-benefit drugs with associated effective dates; no explicit coverage criteria or utilization management rules are included in these chunks.
Coding / Identifiers
| ABIRATERONE ACETATE | Pharmacy benefit drug list entry |
| ACTEMRA | Pharmacy benefit drug list entry |
| ADALIMUMAB | Pharmacy benefit drug list entry |
| BIMZELX | Pharmacy benefit drug list entry |
Provider / Pharmacy Actions and Notices
Reference the Free Market Health Drug List to determine benefit assignment
The Free Market Health Drug List enumerates all drugs included in the program and is split by benefit type (medical benefit and pharmacy benefit); providers must reference this list to determine whether a product is covered under the medical or pharmacy benefit. The list is maintained with an update date (Updated 04/15/2026) and should be used to verify benefit assignment when submitting claims or coordinating where the product will be obtained and billed.
- List is split by medical benefit and pharmacy benefit (see header).
- Updated 04/15/2026 — use the current list date to confirm status.
Use pharmacy-benefit drug entries and Effective Dates when verifying pharmacy coverage
The pharmacy-benefit entries are listed as individual drug names with associated Effective Date values; when billing or dispensing, providers and pharmacies must use the drug name and its Effective Date from this list to confirm inclusion on the pharmacy benefit.
- Example entries from the pharmacy list include ORGOVYX (Effective Date = 11/15/2022), ORKAMBI (04/18/2022), OTEZLA (11/15/2022), and others in the roster.
- Several entries show recent Effective Dates (e.g., PHEBURANE 04/15/2026, POMALIDOMIDE 04/15/2026) — confirm the effective date shown when determining coverage.
Definitions and List Types
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.